Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$35,506,729
+$9,491,035 QoQ
Shares Held
29,603
+4.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
9.18%
of 13F equity value
Holder Rank
#153
of 2,003 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CREATIVE FINANCIAL DESIGNS INC /ADV holds $42,475,367 across 16 Drug Manufacturers - General names. LLY ranks #1 (83.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
29,603 | $35,506,729 | |
| 2 | AMGN |
Amgen Inc
|
6,017 | $2,178,876 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,797 | $2,158,414 | |
| 4 | JNJ |
Johnson & Johnson
|
4,257 | $1,081,150 | |
| 5 | ABBV |
AbbVie Inc.
|
1,839 | $462,765 | |
| 6 | PFE |
Pfizer Inc
|
14,841 | $357,371 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,696 | $340,612 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,756 | $216,420 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,506,729 | 29,603 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $26,015,694 | 28,285 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $30,692,863 | 28,560 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $20,734,525 | 27,175 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,106,554 | 27,076 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $20,157,985 | 24,407 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $12,598,268 | 16,319 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $14,475,373 | 16,339 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $14,498,755 | 16,014 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $11,817,212 | 15,190 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $8,558,431 | 14,682 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $8,584,948 | 15,983 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,540,729 | 16,079 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $5,880,380 | 17,123 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,751,370 | 15,721 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $5,416,759 | 16,752 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $5,510,288 | 16,995 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,016,629 | 17,518 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $1,430,543 | 5,179 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,079,003 | 4,670 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,126,484 | 4,908 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $674,046 | 3,608 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $646,319 | 3,828 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $551,078 | 3,723 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $609,928 | 3,715 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $113,750 | 820 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||